Le pouvoir anticancer des émotions - Références

• 1
Notes
Avant-propos
1. ABRAMS, D. et Weil, A. Integrative Oncology, Oxford University Press, 2009.
2. ANTONI, M. H. « The infl uence of bio-behavioural factors on tumour bio-
logy : pathways and mechanisms », Nat Rev Cancerhttp://www.ncbi.
nlm.nih.gov/pubmed?term=ANTONI%2C M. H., vol. 6, no 3, mars
2006, p. 240-248.
3. COSTANZO, E. S. « Biobehavioral infl uences on cancer progression »,
Immunol Allergy Clin North Am,http://www.ncbi.nlm.nih.gov/pub-
med/21094927 - %23 vol. 31, no 1, février 2011, p. 109-132.
4. ARMAIZ-PENA, G. N. « Neuroendocrine modulation of cancer pro-
gression », Brain Behav Immun,http://www.ncbi.nlm.nih.gov/pub-
med/18638541 - %23 vol. 23, no 1, janvier 2009, p. 10-15.
5. THAKER, P. H. « Neuroendocrine infl uences on cancer biology », Semin
Cancer Biol,http://www.ncbi.nlm.nih.gov/pubmed/18201896 - %23
vol. 18, no 3, juin 2008, p. 164-70.
6. MORENO-SMITH, M. « Impact of stress on cancer metastasis », Future
Oncol,http://www.ncbi.nlm.nih.gov/pubmed/21142861 - %23 vol. 6,
no 12, décembre 2010, p. 1863-1881.
7. SHAHZAD, M. M. « Stress effects on FosB- and interleukin-8 (IL8)-driven
ovarian cancer growth and metastasis », J Biol Chem,http://www.ncbi.
nlm.nih.gov/pubmed/20826776 - %23 vol. 285, no 46, 12 novembre
2010, p. 35462-35470.
8. SOOD, A. K. « Stress hormone-mediated invasion of ovarian cancer cells »,
Clin Cancer Res,http://www.ncbi.nlm.nih.gov/pubmed?term=Stress
hormone-mediated sood 2006 - %23 vol. 12, no 2, 15 janvier 2006,
p. 369-375.
9. GIDRON, Y. « Infl uence of stress and health-behaviour on miRNA
expression », Mol Med Report,http://www.ncbi.nlm.nih.gov/pub-
med/21472261 - %23 vol. 3, no 3, mai-juin 2010, p. 455-457.
10. CHIDA, Y. « Do stress-related psychosocial factors contribute to cancer in-
cidence and survival ? », Nat Clin Pract Oncol,http://www.ncbi.nlm.nih.
gov/pubmed/18493231 - %23 vol. 5, no 8, août 2008, p. 466-475.

2 • LE POUVOIR ANTICANCER DES ÉMOTIONS NOTES : CHAPITRE 3 • 3
Chapitre 3 : LE RETOUR DES ÉMOTIONS
1. SIMONTON, Carl. L’aventure d’une guérison, Belfond, 1993.
2. LESHAN, L. Cancer as a turning point, New York, E. P. Dutton, 1990.
3. LESHAN, L. « An Emotional Life-History Pattern Associated With Neo-
plastic Disease », Annals of the New York Academy of Sciences (Ann NY Acad
Sci.), vol. 125, no 3, 21 janvier 1966, p. 780-793.
4. LESHAN, L. et M. A. Reznikoff. « A Psychological Factor Apparently Asso-
ciated With Neoplastic Disease », Journal of Abnormal and Social Psychology
(J Abnorm Soc Psychol.), vol. 60, mai 1960, p. 439-440.
5. LESHAN, L. « Psychological States as Factors in the Development of Mali-
gnant Disease : A Critical Review », Journal of the National Cancer Institute
(JNCI), vol. 22, no 1, janvier 1959, p. 1-18.
6. BAHNSON, C. B. et M. B. BAHNSON. « Role of the Ego Defenses : Denial and
Repression in the Etiology of Malignant Neoplasm », Ann NY Acad Sci.,
vol. 125, no 3, 21 janvier 1966, p. 827-845.
7. REISER, M. « Psychophysiological Aspects of Cancer. Retrospects and Pros-
pects », Ann NY Acad Sci., vol. 125, no 3, 21 janvier 1966, p. 1028-1055.
8. REICH, W. The Cancer Biopathy, New York, Farrar, Straus and Giroux, 1971.
9. GUINÉE, Robert. Les maladies, mémoires de l’évolution, Éditions Amyris, 2004.
10. MOIROT, Michel. Origine des cancers, édition numérique.
11. THOMAS, C. B. et R. L. GREENSTREET. « Psychobiological characteristics in
youth as predictors of fi ve disease states : suicide, mental illness, hyper-
tension, coronary heart disease and tumor », Johns Hopkins Medical Jour-
nal, vol. 132, no 1, janvier 1973, p. 16-43.
12. THOMAS, C. B. et K. R. DUSZYNSKI. « Closeness to parents and the family
constellation in a prospective study of fi ve disease states : suicide, men-
tal illness, malignant tumor, hypertension, and coronary heart disease »,
Johns Hopkins Medical Journal, vol. 134, no 5, mai 1974, p. 251-270.
13. THOMAS, C. B, K. R. DUSZYNSKI et J. W. SHAFFER. « Family attitudes repor-
ted in youth as potential predictors of cancer », Psychosomatic Medicine
(Psychosom Med), vol. 41, no 4, juin 1979, p. 287-302.
14. HARROWER, M., C. B. THOMAS et A. ALTMAN. « Human fi gure drawings in a
prospective study of six disorders : hypertension, coronary heart disease,
malignant tumor, suicide, mental illness, and emotional disturbance »,
The Journal of Nervous and Mental Disease (J Nerv Ment Dis.), vol. 161, no 3,
sept. 1975, p. 191-199.
15. GROSSARTH-MATICEK, R. « Psychosocial factors as strong predictions of mor-
tality from cancer, ischemic heart disease and stroke : Yugoslav Prospective
Study », Journal of Psychosomatic Research, vol. 29, 1985, p. 167-176.
16. GROSSARTH-MATICEK, R. « Cancer and family structure », Familiendynamik,
vol. 21, no 4, 1976, p. 294-318.
11. ANDERSEN, B. L. « Psychologic intervention improves survival for breast
cancer patients : a randomized clinical trial », Cancer,http://www.ncbi.
nlm.nih.gov/pubmed/19016270 - %23 vol. 113, no 12, 15 décembre
2008, p. 3450-3458.
12. ANDERSEN, B. L. « Biobehavioral, immune, and health benefi ts following
recurrence for psychological intervention participants », Clin Cancer
Res,http://www.ncbi.nlm.nih.gov/pubmed/20530702 - %23 vol. 16, no
12, 15 juin 2010, p. 3270-3278.
13. DENG, G. « Integrative cancer care in a US academic cancer centre : The
Memorial Sloan-Kettering Experience », Curr Oncol,http://www.ncbi.
nlm.nih.gov/pubmed/18769574 - %23 vol. 15, suppl. 2, p. s108.es68-
s108.es71.
14. ELKINS, G. « Mind-body therapies in integrative oncology », Curr Treat
Options Oncolhttp://www.ncbi.nlm.nih.gov/pubmed/21116746 - %23,
vol. 11, no 3-4, décembre 2010, p. 128-40.
15. WESA, K. « Integrative oncology : complementary therapies for cancer
survivors », Hematol Oncol Clin North Amhttp://www.ncbi.nlm.nih.
gov/pubmed/18395154 - %23, vol. 22, no 2, avril 2008, p. 343-353, viii.
16. RICHARDSON, M. A. « Complementary/alternative medicine use in a com-
prehensive cancer center and the implications for oncology », J Clin On-
colhttp://www.ncbi.nlm.nih.gov/pubmed/10893280 - %23, vol. 18, no
13, juillet 2000, p. 2505-2514.
17. KLIGLER, B. « Cost savings in inpatient oncology through an integrative
medicine approach », Am J Manag Carehttp://www.ncbi.nlm.nih.gov/
pubmed/22216749 - %23, vol. 17, no 12, décembre 2011, p. 779-784.
Introduction
1. BECKER, Robert O. et Gary Selden. The Body Electric, Harper, 1998.
Chapitre 2 : PARADIGMES D’ONCOLOGIE
1. DVORAK, H. F. « Tumors : wounds that do not heal. Similarities between
tumor stroma generation and wound healing », New England Journal of
Medicine (NEJM), vol. 315, no 26, 1986, p. 1650-1659.
2. HARACH, H. R. « Occult papillary carcinoma of the thyroid. A “normal”
fi nding in Finland. A systematic autopsy study », Cancer, vol. 56, no 3,
1985, p. 531-538.
3. SERVAN-SCHREIBER, David. Anticancer. Prévenir et lutter grâce à nos défenses
naturelles, Paris, Robert Laffont, 2007.

4 • LE POUVOIR ANTICANCER DES ÉMOTIONS NOTES : CHAPITRE 3 • 5
32. KLOPFER, B. « Psychological variables in human cancer », Journal of Projec-
tive Techniques, vol. 21, p. 331-340.
33. GREENE, W. A. « Psychological factors and reticuloendothelial disease »,
Psychosom Med, vol. 20, p. 124-144.
34. KISSEN, D. M. Lung cancer, inhalation and personality : Psychosomatic aspects of
neoplastic disease, Philadelphie, J. B. Lippincott, 1963.
35. SCHMALE, A. H. et H. IKER. « The psychological setting of uterine cervical
cancer », Ann NY Acad Sci., vol. 125, 1966, p. 807-813.
36. GIOVACCHINI, P. L. et H. MUSLIN. « Ego equilibrium and cancer of the
breast », Psychosom Med, vol. 27, no 6, nov.-déc. 1965, p. 524-532.
37. DEROGATIS, L. « Psychological coping mechanisms and survival time
in metastatic breast cancer », Journal of the American Medical Association
(JAMA), vol. 242, 1979, p. 1504-1508.
38. DATTORE, P. J. « Premorbid personality differentiation of cancer and noncan-
cer groups : A test of the hypothesis of cancer proneness », Journal of Consul-
ting and Clinical Psychology (J Consul Clin Psychol), vol. 48, 1980, p. 388-394.
39. GREER, S. « Cancer and the Mind », Soc Sci Med, vol. 20, 1985, p. 771-853.
40. PETTINGALE, K. W. « Mental attitude to cancer : An additional prognostic
factor », Lancet, vol. 1, 1985, p. 750.
41. TEMOSHOK, L. « Personality, coping style, emotions and cancer : Towards
an integrative model », Cancer Surveys, vol. 6, no 3, 1987, p. 545-567.
42. REDD, W. H. et P. B. JACOBSEN. « Emotions and cancer : New perspectives
on an old question », Cancer, vol. 62, 1988, p. 1871-1879.
43. LEVY, S. M. « Survival hazards analysis in fi rst recurrent breast cancer patients :
Seven-year follow-up », Psychosom Med, vol. 50, no 5, 1998, p. 520-528.
44. SMITH, E. « Fighting cancerous feelings », Psychology Today, mai 1988, p. 22-23.
45. GROSS, J. « Emotional expression on cancer onset and progression », Soc
Sci Med, vol. 28, no 12, 1989, p. 1238-1248.
46. STEIN, S., M. W. LINN et E. M. STEIN. « Psychological correlates of survival
in nursing home cancer patients », Gerontologist, vol. 29, no 2, avril 1989,
p. 224-228.
47. ZEVON, M. A. et B. CORN. Annual Congress of the American Psychological Asso-
ciation, Boston, 1990.
48. LINKINS, R. W. et G. W. COMSTOCK. « Depressed mood and development of
cancer », American Journal of Epidemiology (Am J Epidemiol), vol. 132, no 5,
1990, p. 962-972.
49. JASMIN, C., M. G. LE, P. MARRY et R. HERZBERG. « Evidence for a link between
certain psychological factors and the risk of breast cancer in a case-control
study », Annals of Oncology (Ann Oncol), vol. 1, 1990, p. 22-29.
50. BRISSETTE, Y. « Le cancer : Au-delà des idées reçues », La fi lière émotionnelle,
Psychologie préventive, vol. 19, 1991, p. 15-21.
17. GROSSARTH-MATICEK, R. « Prophylactic effects of psychoanalysis on can-
cer-prone probands, as compared with control groups and behaviour
therapy groups », Journal of Behavior Therapy and Experimental Psychiatry
(J. Behav. Ther. and Exp. Psychiat.), vol. 21, no 2, 1990, p. 91-99.
18. GROSSARTH-MATICEK, R. « Sport activity and personality as elements in
preventing cancer and coronary heart disease », Perceptual and Motor Skills,
vol. 71, 1990, p. 199-209.
19. GROSSARTH-MATICEK, R. « Creative novation behaviour therapy as a pro-
phylactic treatment for cancer and coronary heart disease : Part I – Des-
cription of treatment », Behavior Research and Therapy (Behav. Res. Ther.),
vol. 29, no 1, 1991, p. 1-16.
20. GROSSARTH-MATICEK, R. « Creative novation behaviour therapy as a pro-
phylactic treatment for cancer and coronary heart disease : Part II – Ef-
fects of treatment », Behav. Res. Ther., vol. 29, no 1, 1991, p. 17-31.
21. GROSSARTH-MATICEK, R. « Interaction of psychosocial and physical risk
factors in the causation of mammary cancer, and its prevention through
psychological methods of treatment », Journal of Clinical Psychology,
vol. 56, no 1, 2000, p. 33-50.
22. GROSSARTH-MATICEK, R. et H. J. EYSENCK. « Length of survival and lym-
phocyte percentage in women with mammary cancer as a function of
psychotherapy », Psychological Reports (Psychol Rep.), vol. 65, no 1, août
1989, p. 315-321.
23. GROSSARTH-MATICEK, R., R. FRENTZEL-BEYME et N. BECKER. « Cancer risks
associated with life events and confl icts solution », Cancer Detection and
Prevention (Cancer Detect Prev), vol. 7, 1984, p. 201-209.
24. EYSENCK, H. J. « Health’s character », Psychology Today, vol. 22, déc. 1989,
p. 28-32.
25. SPIEGEL, D. et al. « The effect of psychosocial treatment on survival of pa-
tients with metastatic breast cancer », Lancet, vol. II, no 8668, 14 octobre
1989, p. 888-891.
26. SIMONTON, O. C. Getting Well Again, Los Angeles, Tarcher, 1978.
27. SIMONTON, O. C. The Healing Journey, Authors Choice Press, 2002.
28. SIMONTON, O. C. « Psychological Intervention Treatment of Cancer », Psy-
chosomatics, vol. 21, no 3, 1980, p. 231-233.
29. EVANS, E. A Psychological Study of Cancer, New York, Dodd, Mead, 1926.
30. BLUMBERG, E. M. « Results of psychological testing of cancer patients »,
The Psychological Variables in Human Cancer, Berkeley and Los Angeles,
University of California Press, 1954, p. 30-61.
31. REZNIKOFF, M. « Psychological factors in breast cancer : A preliminary
study of some personality trends in patients with cancer of the breast »,
Psychosom Med, vol. 17, 1955, p. 96-108.

6 • LE POUVOIR ANTICANCER DES ÉMOTIONS NOTES : CHAPITRE 3 • 7
64. REICHE, E. M. V. « Stress, depression, the immune system, and cancer »,
Lancet Oncology, vol. 5, no 10, 2004, p. 617-625.
65. CUNNINGHAM, A. J. et K. WATSON. « How psychological therapy may prolong
survival in cancer patients : New evidence and a simple theory », Integrative
Cancer Therapies (Integr Cancer Ther), vol. 3, no 3, sept. 2004, p. 214-229.
66. ORNISH, D. « Intensive lifestyle changes may affect the progression of
prostate cancer », Journal of Urology, vol. 174, no 3, 2005, p. 1065-1069,
discussion 9-70.
67. OLLONEN, P., LEHTONEN, J. et M. ESKELINEN. « Coping and defending as
risk factors for breast cancer in patients with breast disease : A prospec-
tive case-control study in Kuopio, Finland », Anticancer Research, vol. 25,
no 6C, nov.-déc. 2005, p. 4623-4630.
68. NAKAYA, N. et al. « Personality traits and cancer survival : A Danish cohort
study », British Journal of Cancer (Br J Cancer), vol. 95, no 2, 17 juillet 2006
(publ. électronique : 4 juillet 2006), p. 146-152.
69. BERESFORD, T. « Cancer survival probability as a function of ego defense
(adaptive) mechanisms versus depressive symptoms », Psychosomatics,
vol. 47, 2006, p. 247-253.
70. NAGANO. « A prospective japanese study of the association between per-
sonality and the progression of lung cancer », Inter Med, vol. 45, no 2
2006, p. 57-63.
71. ZOZULYA, A. A., M. V. GABAEVA, O. Y. SOKOLOV et al. « Personality, coping
style, and constitutional neuroimmunology », Journal of Immunotoxicology
(J Immunotoxicol.), vol. 5, no 2, avril 2008, p. 221-225.
72. TRAN, E., F. ROUILLON, J. Y. LOZE et al. « Cancer mortality in patients with
schizophrenia : An 11-year prospective cohort study », Cancer, vol. 115,
no 15, 1er août 2009, p. 3555-3562.
73. SANZO, M., R. COLUCCI, R., M. ARUNACHALAM et al. « Stress as a possible
mechanism in melanoma progression », Dermatology Research and Practice
(Dermatol Res Pract), vol. 2010, 15 mars 2010 (publ. électronique : 27 mai
2010), p. 483-493.
74. GIESE-DAVIS, J., K. COLLIE, K. M. RANCOURT et al. « Decrease in depression
symptoms is associated with longer survival in patients with metastatic breast
cancer : a secondary analysis », Journal of Clinical Oncology (J Clin Oncol), vol. 29,
no 4, 1er février 2011 (publ. électronique : 13 déc. 2010), p. 413-420.
75. BANYAN, Calvin D. The Secret Language of Feelings : A Rational Approach to
Emotional Mastery, Banyan Hypnosis Center, 2002.
76. ADER, R. Psychoneuroimmunology, New York, Academic Press, 1926.
77. LUTGENDORF, S. K. « Social support, psychological distress, and natural
killer cell activity in ovarian cancer », Journal of Clinical Oncology (J Clin
Oncol), vol. 23, no 28, 2005, p. 7105-7113.
51. BALTRUSCH, H. J., W. STANGEL et I. TITZE. « Stress, cancer and immu-
nity. New developments in biopsychosocial and psychoneuroimmu-
nologic research », Acta Neurologica (Napoli), vol. 13, no 4, août 1991,
p. 315-327.
52. FAWZY, F. I., M. E. KEMENY, N. W. FAWZY et al. « A structured psychiatric
intervention for cancer patients : II. Changes over time in immunological
measures », Archives of General Psychiatry (Arch Gen Psychiatry), vol. 47, no
8, août 1990, p. 729-735.
53. FAWZY, F. J., N. W. FAWZY, C. S. HYUN, et al. « Malignant melanoma : Ef-
fects of an early structured psychiatric intervention, coping and affective
state on recurrence and survival 6 years later », Arch Gen Psychiatry, vol.
50, no 9, sept. 1993, p. 681-689.
54. FOX, C. M., A. P. HARPER, G. C. HYNER et R. M. LYLE. « Loneliness, emo-
tional repression, marital quality, and major life events in women who
develop breast cancer », Journal of Community Health, vol. 19, no 6, déc.
1994, p. 467-482.
55. BRYLA, C. M. « The relationship between stress and the development
of breast cancer : A literature review », Oncology Nursing Forum (ONF),
vol. 23, no 3, avril 1996, p. 441-448.
56. PENNINX, B. W. et al. « Chronically depressed mood and cancer risk in
older persons », JNCI, vol. 90, no 24, 16 déc. 1998, p. 1888-1893.
57. FALLER, H. « Coping, distress and survival among patients with lung can-
cer », Arch Gen Psychiatry, vol. 56, 1999, p. 756-762.
58. WALKER, L. G. « Psychological factors can predict the response to pri-
mary chemotherapy in patients with locally advanced breast cancer »,
European Journal of Cancer (Eur J Cancer), vol. 35, no 13, déc. 1999,
p. 1783-1788.
59. WATSON, M. « Infl uence of psychological response on survival in breast
cancer : A population-based cohort study », Lancet, vol. 354, no 9187,
1999, p. 1331-1336.
60. REYNAERT, C. « Psychogenèse du cancer : Entre mythes, abus et réalité »,
Bulletin du cancer, vol. 87, no 9, 2000, p. 655-664.
61. PRICE, M. A. « The role of psychosocial factors in the development of
breast carcinoma : Part II. Life event stressors, social support, defense
style, and emotional control and their interactions », Cancer, vol. 91, no 4,
2001, p. 686-697.
62. BROWN, K. « Psychological distress and cancer survival : A follow-up 10
years after diagnosis », Psychosom Med, vol. 65, 2003, p. 636-643.
63. LILLBERG, K. et al. « Stressful life events and risk of breast cancer in 10
808 women : A cohort study », American Journal of Epidemiology, vol. 157,
no 5, 1er mars 2003, p. 415-423.

8 • LE POUVOIR ANTICANCER DES ÉMOTIONS NOTES : CHAPITRE 4 • 9
92. THAKER, P. H. « The neuroendocrine impact of chronic stress on cancer »,
Seminars in Cancer Biology, vol. 18, no 3, 2008, p. 164-170.
93. THAKER, P. H., S. K. LUTGENDORF et A. K. SOOD. « The neuroendocrine im-
pact of chronic stress on cancer », Cell Cycle, vol. 6, no 4, 15 février 2007
(publ. électronique : 9 février 2007), p. 430-433.
94. THAKER, P. H. et A. K. SOOD. « The Neuroendocrine Impact of Chronic Stress
on Cancer », Seminars in Cancer Biology, vol. 18, no 3, juin 2008, p. 164-170.
95. SHAHZAD, M. M., J. M. AREVALO, G. N. ARMAIZ-PENA et al. « Stress effects
on FosB-and interleukin-8 (IL8)-driven ovarian cancer growth and me-
tastasis », The Journal of Biological Chemistry (J Biol Chem), vol. 285, no 46,
12 nov. 2010 (publ. électronique : 8 sept. 2010), p. 35 462-35 470.
96. VISINTAINER, M. A., J. R. VOLPICELLI et M. E. SELIGMAN. « Tumor rejection
in rats after inescapable or escapable shock », Science, vol. 216, no 4544,
23 avril 1982, p. 437-439.
97. YANG, E. V., S. J. KIM, E. L. DONOVAN et al. « Norepinephrine upregulates
VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines :
Implications for stress-related enhancement of tumor progression »,
Brain, Behavior, and Immunity, vol. 23, no 2, février 2009 (publ. électro-
nique : 21 oct. 2008), p. 267-275.
98. YANG, E. V., A. K. SOOD, M. CHEN et al. « Norepinephrine up-regulates the
expression of vascular endothelial growth factor, matrix metalloprotei-
nase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells »,
Cancer Research, vol. 66, no 21, 1er nov. 2006, p. 10 357-10 364.
99. MORENO-SMITH, M., C. LU, M. M. SHAHZAD et al. « Dopamine blocks stress
mediated ovarian carcinoma growth », Clinical Cancer Research, vol. 17,
no 11, 1er juin 2011 (publ. électronique : 29 avril 2011), p. 3649-3659.
100. LUTGENDORF, S.K., S. COLE, E. COSTANZO et al. « Stress-related mediators stimu-
late vascular endothelial growth factor secretion by two ovarian cancer cell
lines », Clinical Cancer Research, vol. 9, no 12, 1er oct. 2003, p. 4514-4521.
101. SASTRY K. S., Y. KARPOVA, S. PROKOPOVICH et al. « Epinephrine protects
cancer cells from apoptosis via activation of cAMP-dependent protein
kinase and BAD phosphorylation », J Biol Chem, vol. 282, no 19, 11 mai
2007 (publ. électronique : 12 mars 2007), p. 14 094-14 100.
102. SOOD A. K., R. BHATTY, A. A. KAMAT et al. « Stress hormone-mediated
invasion of ovarian cancer cells », Clinical Cancer Research, vol. 12, no 2,
15 janvier 2006, p. 369-375.
103. GIRALDI T., L. PERISSIN, S. ZORZET et V. RAPOZZI. « Rotational stress reduce
the effectiveness of antitumor drugs in mice », Ann NY Acad Sci, vol. 741,
1994, p. 234-243.
104. SAUL A. N., T. M. OBERYSZYN, C. DAUGHERTY et al. « Chronic stress and suscepti-
bility to skin cancer », JNCI, vol. 97, no 23, 7 déc. 2005, p. 1760-1767.
78. MARUCHA, P. T. « TNF-alpha levels in cancer patients relate to social variables »,
Brain, Behavior, and Immunity, vol. 19, no 6, nov. 2005, p. 521-525.
79. GLASER, R. « Stress depresses interferon production by leukocytes conco-
mitant with a decrease in Natural Killer Cell Activity », Behavioral Neuro-
science, vol. 199, p. 675-678.
80. LEVY, S. « Correlation of stress factors with sustained depression of natu-
ral killer cell activity and predicted prognosis in patients with breast can-
cer », Journal of Clinical Oncology (J Clin Oncol), vol. 5, no 3, 1987, p. 348-353.
81. IRWIN, M., M. Daniels, S. C. Risch et al. « Plasma cortisol and natural kil-
ler cell activity during bereavement », Biological Psychiatry, vol. 24, no 2,
juin 1988, p. 173-178.
82. BEN-ELIYAHU, S. « Suppression of NK cell activity and of resistance to me-
tastasis by stress : A role for adrenal catecholamines and beta-adrenocep-
tors », Neuroimmunomodulation, vol. 8, no 3, 2000, p. 154-164.
83. KIECOLT-GLASER, J. K. « Psycho-oncology and cancer : Psychoneuroimmuno-
logy and cancer », Ann Oncol., vol. 13, suppl. 4, 2002, p. 165-169.
84. COHEN, M. et POLLACK. « Mothers with breast cancer and their adult
daughters : The relationship between mothers’ reaction to breast cancer
and their daughters’ emotional and neuroimmune status », Psychosom
Med, vol. 67, no 1, janvier-fév. 2005, p. 64-71.
85. KOVÁCS, Z. A., L. G. PUSKÁS, A. JUHÁSZ et al. « Hypnosis upregulates the expres-
sion of immune-related genes in lymphocytes », Psychotherapy and Psychosoma-
tics, vol. 77, no 4, 2008 (publ. électronique : 25 avril 2008), p. 257-259.
86. HALL, H. R. « Hypnosis and the immune system : A review with implications
for cancer and the psychology of healing », American Journal of Clinical Hyp-
nosis (Am J Clin Hypn), vol. 25, nos 2-3, oct. 1982-janvier 1983, p. 92-103.
87. KIECOLT-GLASER, J. K., R. GLASER, D. WILIGER et al. « Psychosocial enhan-
cement of immunocompetence in a geriatric population », Health Psycho-
logy, vol. 4, 1985, p. 25-41.
88. KIECOLT-GLASER, J. K. et R. GLASER. « Psychoneuroimmunology : Can psy-
chological interventions modulate immunity? », Journal of Consulting and
clinical Psychology (J Consul Clin Psychol), vol. 60, 1992, p. 569-575.
89. BENNETT, M. P. « The effect of mirthful laughter on stress and natural kil-
ler cell activity », Alternative Therapies in Health and Medicine (Altern Ther
Health Med), vol. 9, no 2, mars-avril 2003, p. 38-45.
90. BERK, L. « Humor associated laughter decreases cortisol and increases
spontaneous lymphocyte blastogenesis », Clinical Research, vol. 36, 1988,
p. 435. (Extrait.)
91. ANTONI, M. H. « The infl uence of bio-behavioural factors on tumour bio-
logy : Pathways and mechanisms », Nature Reviews Cancer, vol. 6, no 3,
2006, p. 240-248.